With your own knowledge and the help of the following document:

Document 1 (Title: Non-Classical Manifestations of Coronary Artery Disease): While classic angina typically presents as substernal chest pressure exacerbated by exertion and relieved by rest or nitroglycerin, atypical presentations of myocardial ischemia occur frequently, particularly in women, diabetic patients, and elderly individuals. These variant manifestations, sometimes termed angina equivalents, include exertional dyspnea without chest discomfort, epigastric or abdominal discomfort, and jaw or arm pain without accompanying chest sensations. Upper abdominal discomfort represents a particularly challenging variant that may be misattributed to gastrointestinal etiologies, delaying appropriate cardiac evaluation. The pathophysiological basis for these atypical presentations involves complex neurological mechanisms, with cardiac nociceptive signals sharing afferent pathways with those from other visceral structures, particularly the esophagus and upper gastrointestinal tract. Patients with significant cardiovascular risk factors reporting upper abdominal discomfort that correlates with physical exertion warrant careful evaluation for potential cardiac ischemia, even in the absence of classic chest pain. Diagnostic approaches differ markedly between suspected cardiac and gastrointestinal etiologies. While endoscopic evaluation may seem intuitive for abdominal symptoms, non-invasive cardiac assessment should take precedence when the clinical presentation suggests possible angina equivalent. Exercise stress testing, with or without imaging, provides valuable diagnostic and prognostic information by detecting inducible myocardial ischemia under controlled conditions. Functional testing such as hydrogen breath testing for small intestinal bacterial overgrowth or abdominal ultrasonography for biliary disease may be appropriate in patients where cardiac etiologies have been excluded or when symptoms and risk profile suggest primary gastrointestinal pathology.
Document 2 (Title: Cardiovascular Applications of Organic Nitrates): Nitroglycerin (glyceryl trinitrate) represents a cornerstone therapy in cardiovascular medicine with distinctive pharmacological properties determining its clinical applications and administration considerations. Chemical structure analysis identifies this compound as a unique organic nitrate ester distinct from other nitrates including isosorbide dinitrate and isosorbide mononitrate, despite their related pharmacological effects through nitric oxide donation. Therapeutic applications focus predominantly on angina pectoris management through coronary vasodilation effects, though pharmacokinetic considerations significantly influence administration approaches. The compound undergoes extensive first-pass hepatic metabolism resulting in very low oral bioavailability, necessitating alternative administration routes including sublingual, transdermal, and intravenous formulations for clinical efficacy. Sublingual administration provides rapid onset for acute angina attacks, while transdermal systems deliver sustained release for prophylaxis. Hemodynamic effects demonstrate a predominant venodilation profile at therapeutic doses, resulting in reduced cardiac preload and myocardial oxygen demand—effects particularly beneficial in left ventricular failure states. Direct arterial vasodilation occurs at higher doses, potentially resulting in reduced systemic vascular resistance and blood pressure reduction through afterload effects. Adverse effects include reflex tachycardia, headache, and potential hypotension, though notably not methemoglobinemia, which only occurs with excessive dosing of certain other nitrates. The compound's clinical utility in acute coronary syndromes, heart failure, and perioperative hypertension management demonstrates its enduring importance in cardiovascular pharmacotherapy despite numerous newer agent introductions. Administration protocols require careful titration to balance therapeutic effects with potential adverse hemodynamic consequences, particularly in volume-depleted patients.
Document 3 (Title: Emergent Interventions for Limb-Threatening Ischemia): Acute limb ischemia represents a vascular emergency requiring rapid assessment and intervention to prevent permanent tissue damage and limb loss. The condition results from sudden interruption of arterial blood flow, most commonly due to embolism or thrombosis, with the lower extremities affected more frequently than upper extremities. Cardioembolic events account for approximately 80% of acute arterial emboli, with atrial fibrillation representing the predominant cardiac source. The clinical presentation follows the classic six Ps of ischemia: pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia (cold). Neurological manifestations—paresthesia and paralysis—represent particularly ominous signs indicating advanced ischemia with tissue compromise. Initial management focuses on preventing thrombus propagation and establishing definitive revascularization. Immediate systemic anticoagulation with unfractionated heparin constitutes the critical first therapeutic intervention, ideally administered as an intravenous bolus followed by continuous infusion titrated to therapeutic aPTT levels. This prevents thrombus propagation while diagnostic and therapeutic planning proceeds. Antiplatelet therapy with aspirin provides modest complementary benefit but should not delay anticoagulation. Revascularization options include surgical thromboembolectomy and endovascular approaches such as catheter-directed thrombolysis. Tissue plasminogen activator, while effective for cerebral ischemia within its narrow therapeutic window, carries excessive bleeding risk in peripheral arterial occlusion and requires longer infusion periods incompatible with limb salvage timeframes. The choice between surgical and endovascular approaches depends on ischemia severity, anatomic considerations, patient comorbidities, and institutional expertise, with surgery generally preferred for advanced ischemia.

Answer the following multiple-choice question.
Question: A 68-year-old man presents to the emergency department with leg pain. He states that the pain started suddenly while he was walking outside. The patient has a past medical history of diabetes, hypertension, obesity, and atrial fibrillation. His temperature is 99.3°F (37.4°C), blood pressure is 152/98 mmHg, pulse is 97/min, respirations are 15/min, and oxygen saturation is 99% on room air. Physical exam is notable for a cold and pale left leg. The patient’s sensation is markedly diminished in the left leg when compared to the right, and his muscle strength is 1/5 in his left leg. Which of the following is the best next step in management?
Options:
A. Graded exercise and aspirin
B. Heparin drip
C. Surgical thrombectomy
D. Tissue plasminogen activator

Respond strictly in valid JSON format as follows:
{"answer_choice": "A"} ← if A is the answer
Output only the JSON object. Do not include any explanation, commentary, markdown, or extra text.